These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17899106)

  • 21. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
    Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
    Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative staging of renal cell carcinoma with inferior vena cava thrombus using multidetector CT and MRI: prospective study with histopathological correlation.
    Hallscheidt PJ; Fink C; Haferkamp A; Bock M; Luburic A; Zuna I; Noeldge G; Kauffmann G
    J Comput Assist Tomogr; 2005; 29(1):64-8. PubMed ID: 15665685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of multiphasic contrast-enhanced MR textures in differentiating small renal mass subtypes.
    Hoang UN; Mojdeh Mirmomen S; Meirelles O; Yao J; Merino M; Metwalli A; Marston Linehan W; Malayeri AA
    Abdom Radiol (NY); 2018 Dec; 43(12):3400-3409. PubMed ID: 29858935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MR imaging of renal cortical tumours: qualitative and quantitative chemical shift imaging parameters.
    Karlo CA; Donati OF; Burger IA; Zheng J; Moskowitz CS; Hricak H; Akin O
    Eur Radiol; 2013 Jun; 23(6):1738-44. PubMed ID: 23300041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance imaging of large chromophobe renal cell carcinomas.
    Sasaguri K; Irie H; Kamochi N; Nakazono T; Yamaguchi K; Uozumi J; Kudo S
    Jpn J Radiol; 2010 Jul; 28(6):453-9. PubMed ID: 20661696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inter-rater agreement in the characterization of cystic renal lesions on contrast-enhanced MRI.
    Seppala N; Kielar A; Dabreo D; Duigenan S
    Abdom Imaging; 2014 Dec; 39(6):1267-73. PubMed ID: 24869788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-phase signal intensity loss in solid renal masses on dual-echo gradient-echo MRI: association with malignancy and pathologic classification.
    Childs DD; Clingan MJ; Zagoria RJ; Sirintrapun J; Tangtiang K; Anderson A; Leyendecker JR
    AJR Am J Roentgenol; 2014 Oct; 203(4):W421-8. PubMed ID: 25247971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The staging of renal-cell carcinomas in MRT and CT--a prospective histologically controlled study].
    Hallscheidt P; Stolte E; Roeren T; Pomer S; Drehmer I; Kauffmann GW
    Rofo; 1998 Feb; 168(2):165-70. PubMed ID: 9519049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of papillary renal cell carcinoma subtypes on CT and MRI.
    Egbert ND; Caoili EM; Cohan RH; Davenport MS; Francis IR; Kunju LP; Ellis JH
    AJR Am J Roentgenol; 2013 Aug; 201(2):347-55. PubMed ID: 23883215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of blood oxygenation level-dependent (BOLD) MR imaging in differentiation of renal solid mass and grading of renal cell carcinoma (RCC): analysis based on the largest cross-sectional area versus the entire whole tumour.
    Wu GY; Suo ST; Lu Q; Zhang J; Zhu WQ; Xu JR
    PLoS One; 2015; 10(4):e0123431. PubMed ID: 25875306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma.
    Cornelis F; Tricaud E; Lasserre AS; Petitpierre F; Bernhard JC; Le Bras Y; Yacoub M; Bouzgarrou M; Ravaud A; Grenier N
    Eur Radiol; 2015 Jan; 25(1):24-31. PubMed ID: 25117747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemosiderin deposition in papillary renal cell carcinoma and its potential to mask enhancement on MRI: analysis of 110 cases.
    Takahashi H; Kawashima A; Inoue A; Kozaka K; Potretzke TA; Froemming AT; Boorjian SA; Humphreys MR; Takahashi N
    Eur Radiol; 2020 Nov; 30(11):6033-6041. PubMed ID: 32518984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the extracellular volume fraction for the grading of clear cell renal cell carcinoma: first results and histopathological findings.
    Adams LC; Jurmeister P; Ralla B; Bressem KK; Fahlenkamp UL; Engel G; Siepmann S; Wagner M; Hamm B; Busch J; Makowski MR
    Eur Radiol; 2019 Nov; 29(11):5832-5843. PubMed ID: 30887194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusion-weighted imaging using 3.0 T MRI as a possible biomarker of renal tumors.
    Mirka H; Korcakova E; Kastner J; Hora M; Hes O; Hosek P; Ferda J
    Anticancer Res; 2015 Apr; 35(4):2351-7. PubMed ID: 25862900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
    Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N
    AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility and limitations of 3-Tesla diffusion-weighted magnetic resonance imaging for differentiation of renal tumors.
    Sevcenco S; Heinz-Peer G; Ponhold L; Javor D; Kuehhas FE; Klingler HC; Remzi M; Weibl P; Shariat SF; Baltzer PA
    Eur J Radiol; 2014 Jun; 83(6):909-913. PubMed ID: 24709332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Imaging tumor extension of renal cell carcinomas with magnetic resonance tomography. Improved tumor-tissue contrast with Gd-DTPA-assisted spin-echo sequences and simultaneous fat suppression].
    Venz S; Hierholzer J; Keske U; Friedrichs R; Schröder R; Siewert C; Hosten N; Felix R
    Aktuelle Radiol; 1998 May; 8(3):119-24. PubMed ID: 9645248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [MR imaging features of different renal cell carcinoma subtypes].
    Wu B; Peng WJ; Gu YJ; Yang TX; Jiang ZX; Zhang HL; Dai B; Ye DW; Kong YY; Du X
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):825-30. PubMed ID: 19173827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of intratumoral susceptibility signals using T2*-weighted gradient echo MRI in patients with clear cell renal cell carcinoma.
    Yu S; Qiu J; Zhang J; Pan L; Xing S; Zhang L
    PLoS One; 2013; 8(11):e79597. PubMed ID: 24265780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal neoplasms amenable to partial nephrectomy: MR imaging.
    Pretorius ES; Siegelman ES; Ramchandani P; Cangiano T; Banner MP
    Radiology; 1999 Jul; 212(1):28-34. PubMed ID: 10405716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.